학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 605건 | 목록 1~20
Academic Journal
Vaghi C; Department of Hematology, Oncology, and Molecular Medicine, Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore, 3, 20162, Milan, Italy.; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Tosi F; Department of Hematology, Oncology, and Molecular Medicine, Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore, 3, 20162, Milan, Italy.; Mauri G; Department of Hematology, Oncology, and Molecular Medicine, Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore, 3, 20162, Milan, Italy.; Bonazzina E; Department of Hematology, Oncology, and Molecular Medicine, Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore, 3, 20162, Milan, Italy.; Amatu A; Department of Hematology, Oncology, and Molecular Medicine, Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore, 3, 20162, Milan, Italy.; Bencardino K; Department of Hematology, Oncology, and Molecular Medicine, Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore, 3, 20162, Milan, Italy.; Piscazzi D; Department of Hematology, Oncology, and Molecular Medicine, Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore, 3, 20162, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Roazzi L; Department of Hematology, Oncology, and Molecular Medicine, Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore, 3, 20162, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Villa F; Department of Hematology, Oncology, and Molecular Medicine, Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore, 3, 20162, Milan, Italy.; Maggi M; Department of Hematology, Oncology, and Molecular Medicine, Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore, 3, 20162, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Monti L; Department of Hematology, Oncology, and Molecular Medicine, Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore, 3, 20162, Milan, Italy.; Bombelli A; Department of Hematology, Oncology, and Molecular Medicine, Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore, 3, 20162, Milan, Italy.; Marrapese G; Department of Hematology, Oncology, and Molecular Medicine, Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore, 3, 20162, Milan, Italy.; Ghezzi S; Department of Hematology, Oncology, and Molecular Medicine, Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore, 3, 20162, Milan, Italy.; Patelli G; Department of Hematology, Oncology, and Molecular Medicine, Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore, 3, 20162, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy.; Ros J; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Medical Oncology Department, Vall d'Hebron University Hospital, Universitat Auntònoma de Barcelona, Barcelona, Spain.; Elez E; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Medical Oncology Department, Vall d'Hebron University Hospital, Universitat Auntònoma de Barcelona, Barcelona, Spain.; Sartore-Bianchi A; Department of Hematology, Oncology, and Molecular Medicine, Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore, 3, 20162, Milan, Italy. andrea.sartorebianchi@ospedaleniguarda.it.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. andrea.sartorebianchi@ospedaleniguarda.it.; Siena S; Department of Hematology, Oncology, and Molecular Medicine, Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore, 3, 20162, Milan, Italy. salvatore.siena@ospedaleniguarda.it.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. salvatore.siena@ospedaleniguarda.it.
Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 7600076 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1950 (Electronic) Linking ISSN: 00126667 NLM ISO Abbreviation: Drugs Subsets: MEDLINE
Academic Journal
Nasca V; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; Bergamo F; Medical Oncology 1, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.; Foltran L; Centro Riferimento Oncologico (CRO) Aviano, National Cancer Institute IRCCS, Aviano, Italy.; Antonuzzo L; Clinical Oncology Unit, Careggi University Hospital, Florence, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; Bencardino K; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Dell'Aquila E; IRCCS Istituto Nazionale Tumori Regina Elena, Rome, Italy.; Corallo S; SC Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.; Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy.; Spallanzani A; Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.; Brunetti O; IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy.; Spada D; ASST Cremona, Cremona, Italy.; Tamberi S; Oncology Unit, Ospedale Santa Maria Delle Croci, Ravenna, Italy.; Cella CA; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, Istituto Europeo Di Oncologia IRCCS, Milan, Italy.; Avallone A; Istituto Nazionale Dei Tumori Napoli IRCCS Pascale, Naples, Italy.; Fornaro L; U.O. Oncologia Medica 2 Universitaria, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.; Di Donato S; Nuovo Ospedale S. Stefano, Prato, Italy.; Strippoli A; Comprehensive Cancer Center, Policlinico Universitario Gemelli IRCCS, Rome, Italy.; Puccini A; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy.; Tamburini E; Department of Oncology and Palliative Care, Ospedale Cardinale Panico, Tricase, Italy.; Palermo F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; Morano F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; Pietrantonio F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy. filippo.pietrantonio@istitutotumori.mi.it.; Raimondi A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
Academic Journal
Sciortino C; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy.; Nichetti F; Medical Oncology 1, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.; Bergamo F; Medical Oncology 1, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.; Palermo F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy.; Tamberi S; Oncology Unit, Ospedale Santa Maria elle Croci Ravenna AUSL Romagna, Italy; DIMEC University of Bologna, Italy.; Vivaldi C; Unit of Medical Oncology 2, University Hospital of Pisa, Pisa, Italy.; Ongaro E; Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano, IRCCS, Aviano (PN), Italy.; Arcangeli G; Department of Medical Oncology, ASST Spedali Civili, Brescia, Italy.; Marchesi S; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy.; Giommoni E; Oncology Unit-Careggi University Hospital, Florence, Italy.; Cella CA; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, IEO IRCCS, European Institute of Oncology, Milano, Italy.; Pircher C; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy.; Chiaramonte A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy.; Bencardino K; Niguarda Cancer Center, Dipartimento di Ematologia, Oncologia e Medicina Molecolare, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Sottotetti E; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy.; Martinetti A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy.; Rapposelli IG; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori', Meldola, Italy.; Corallo S; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.; Di Donato S; Department of Medical Oncology, General Hospital, Prato, Italy.; Murialdo R; Department of Internal Medicine and Medical Specialties (Di.M.I.), University of Genoa and IRCCS AOU San Martino-IST, Genoa, Italy.; Delliponti L; Unit of Medical Oncology 2, University Hospital of Pisa, Pisa, Italy.; Salvatore L; Medical Oncology, Università Cattolica del Sacro Cuore, Rome, Italy; Medical Oncology, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS Rome, Italy.; Bozzarelli S; Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center IRCCS, Rozzano (Milan), Italy.; Dell'Aquila E; IRCCS Regina Elena National Cancer Institute, Rome, Italy.; Miceli R; Biostatistics for Clinical Research Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.; Carnaghi C; Medical Oncology Unit, Humanitas Istituto Clinico Catanese, Misterbianco, Catania 95045, Italy.; Tomasello G; Department of Medical Oncology, ASST of Crema, Hospital of Crema, Crema, Italy.; Rivizzigno P; Codice Viola, Pancreatic Cancer Advocacy Group, 20855, Lesmo (MB), Italy.; Bonomi M; Division of Medical Oncology, ASST of Cremona, Hospital of Cremona, Cremona, Italy.; Mannavola F; Division of Medical Oncology, A.O.U. Consorziale Policlinico di Bari, Bari, Italy.; Forti L; Division of Oncology, University Maggiore Hospital della Carità, Novara, Italy.; Garajovà I; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.; Attademo L; Oncology Unit, Ospedale del Mare, 80147 Naples, Italy.; Galassi B; Department of Medical Oncology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.; Chiari R; UOC Oncologia, AST Pesaro - Urbino, Pesaro, Italy.; Leone F; Department of Oncology, ASL BI, Nuovo Ospedale degli Infermi, 13875 Ponderano, Italy.; Garattini SK; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Department of Oncology, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.; Tamburini E; Department of Oncology and Palliative Care, Cardinale G Panico, Tricase City Hospital, Tricase, Italy.; Pietrantonio F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy.; Niger M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy. Electronic address: Monica.niger@istitutotumori.mi.it.
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 100958385 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3562 (Electronic) Linking ISSN: 15908658 NLM ISO Abbreviation: Dig Liver Dis Subsets: MEDLINE
Academic Journal
Amatu A; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Patelli G; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy; IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy.; Zampino MG; European Institute of Oncology IRCCS, IEO, Milan, Italy.; Bergamo F; Oncology Institute of Venice IRCCS, IOV, Padua, Italy.; Mosconi S; ASST Papa Giovanni XXIII, Bergamo, Italy.; Tosi F; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Ciardiello D; European Institute of Oncology IRCCS, IEO, Milan, Italy.; Lonardi S; Oncology Institute of Venice IRCCS, IOV, Padua, Italy.; Negrini G; ASST Papa Giovanni XXIII, Bergamo, Italy.; Sibio D; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Gerardi MA; European Institute of Oncology IRCCS, IEO, Milan, Italy.; Galuppo S; Oncology Institute of Venice IRCCS, IOV, Padua, Italy.; Filippone FR; ASST Papa Giovanni XXIII, Bergamo, Italy.; Carnevali P; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Borin S; European Institute of Oncology IRCCS, IEO, Milan, Italy.; Pilati P; Oncology Institute of Venice IRCCS, IOV, Padua, Italy.; Poiasina E; ASST Papa Giovanni XXIII, Bergamo, Italy.; Bonazzina E; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Gervaso L; European Institute of Oncology IRCCS, IEO, Milan, Italy.; Mammano E; Sant'Antonio Hospital, University of Padua, Padua, Italy.; Bracco F; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Bergamaschi L; European Institute of Oncology IRCCS, IEO, Milan, Italy.; Spolverato G; Department of Oncological, Surgical, and Gastroenterological Sciences, University of Padua, Padua, Italy.; Origi M; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Romario UF; European Institute of Oncology IRCCS, IEO, Milan, Italy.; Mauri G; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Fazio N; European Institute of Oncology IRCCS, IEO, Milan, Italy.; Forti E; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; De Roberto G; European Institute of Oncology IRCCS, IEO, Milan, Italy.; Cristofori C; Oncology Institute of Venice IRCCS, IOV, Padua, Italy.; Burti C; ASST Papa Giovanni XXIII, Bergamo, Italy.; Asmundo L; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Funicelli L; European Institute of Oncology IRCCS, IEO, Milan, Italy.; Ramondo G; Oncology Institute of Venice IRCCS, IOV, Padua, Italy.; Bonaffini PA; ASST Papa Giovanni XXIII, Bergamo, Italy; School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.; Mariano S; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Lazzari L; IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy.; Ghezzi S; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Isella C; Department of Oncology, University of Turin, Turin, Italy; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.; Cantarella D; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.; Aquilano MC; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Bottiglieri L; European Institute of Oncology IRCCS, IEO, Milan, Italy.; Bonoldi E; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Mutignani M; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Torri V; Department of Clinical Oncology, Mario Negri Institute for Pharmalogical Research IRCCS, Milan, Italy.; Medico E; Department of Oncology, University of Turin, Turin, Italy; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.; Bardelli A; IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy; Department of Oncology, Molecular Biotechnology Center, University of Turin, Turin, Italy.; Marsoni S; IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy.; Vanzulli A; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.; Palazzi MF; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Ferrari GC; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Bencardino K; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Sartore-Bianchi A; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.; Siena S; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy. Electronic address: salvatore.siena@unimi.it.
Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
Academic Journal
Galli E; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano (La Statale), Milan, Italy; Niguarda Cancer Center, Department of Hematology, Oncology and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Patelli G; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano (La Statale), Milan, Italy; Niguarda Cancer Center, Department of Hematology, Oncology and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy; IFOM ETS - The AIRC Institute of Molecular Oncology, Milan, Italy. Electronic address: giorgio.patelli@ospedaleniguarda.it.; Villa F; Niguarda Cancer Center, Department of Hematology, Oncology and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Gri N; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano (La Statale), Milan, Italy; Niguarda Cancer Center, Department of Hematology, Oncology and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Mazzarelli C; Hepatology and Gastroenterology Unit, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Mangoni I; Department of General Surgery and Transplantation, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Sgrazzutti C; Department of Radiology, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Ghezzi S; Niguarda Cancer Center, Department of Hematology, Oncology and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Sartore-Bianchi A; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano (La Statale), Milan, Italy; Niguarda Cancer Center, Department of Hematology, Oncology and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy; Division of Clinical Research and Innovation, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Belli LS; Hepatology and Gastroenterology Unit, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; De Carlis L; Department of General Surgery and Transplantation, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Vanzulli A; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano (La Statale), Milan, Italy; Department of Radiology, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Siena S; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano (La Statale), Milan, Italy; Niguarda Cancer Center, Department of Hematology, Oncology and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Bencardino K; Niguarda Cancer Center, Department of Hematology, Oncology and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1967 (Electronic) Linking ISSN: 03057372 NLM ISO Abbreviation: Cancer Treat Rev Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Bencardino, K.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어